Accès gratuit
Numéro
Med Sci (Paris)
Volume 29, Numéro 2, Février 2013
Page(s) 139 - 141
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2013292008
Publié en ligne 28 février 2013
  1. Stocchi F, Nordera G, Marsden CD. Strategies for treating patients with advanced Parkinson’s disease with disastrous fluctuations and dyskinesias. Clin Neuropharmacol 1997 ; 20 : 95–115. [CrossRef] [PubMed]
  2. Fahn S. How do you treat motor complications in Parkinson’s disease: medicine, surgery, or both? Ann Neurol 2008 ; 64 : S56–S64. [CrossRef] [PubMed]
  3. Guigoni C, Doudnikoff E, Li Q, et al. Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates. Neurobiol Dis 2007 ; 26 : 452–463. [CrossRef] [PubMed]
  4. Berthet A, Porras G, Doudnikoff E, et al. Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia. J Neurosci 2009 ; 29 : 4829–4835. [CrossRef] [PubMed]
  5. Bezard E, Gross CE, Qin L, et al. L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain. Neurobiol Dis 2005 ; 18 : 323–335. [CrossRef] [PubMed]
  6. Ahmed MR, Berthet A, Bychkov E, et al. Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson’s disease. Sci Transl Med 2010 ; 2 : 28ra28. [CrossRef] [PubMed]
  7. Hallett PJ, Dunah AW, Ravenscroft P, et al. Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson’s disease. Neuropharmacology 2005 ; 48 : 503–516. [CrossRef] [PubMed]
  8. Gardoni F, Polli F, Cattabeni F, Di Luc M. Calcium-calmodulin-dependent protein kinase II phosphorylation modulates PSD-95 binding to NMDA receptors. Eur J Neurosci 2006 ; 24 : 2694–2704. [CrossRef] [PubMed]
  9. Silverdale MA, Kobylecki C, Hallett PJ, et al. Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate. Synapse 2010 ; 64 : 177–180. [CrossRef] [PubMed]
  10. Fiorentini C, Gardoni F, Spano P, et al. Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. J Biol Chem 2003 ; 278 : 20196–20202. [CrossRef] [PubMed]
  11. Yao WD, Spealman, R.D, Zhang J. Dopaminergic signaling in dendritic spines. Biochem Pharmacol 2008 ; 75 : 2055–2069. [CrossRef] [PubMed]
  12. Zhang J, Xu TX, Hallett PJ, et al. PSD-95 uncouples dopamine-glutamate interaction in the D1/PSD-95/NMDA receptor complex. J Neurosci 2009 ; 29 : 2948–2960. [CrossRef] [PubMed]
  13. Nash JE, Johnston TH, Collingridge GL, et al. Subcellular redistribution of the synapse-associated proteins PSD-95 and SAP97 in animal models of Parkinson’s disease and L-DOPA-induced dyskinesia. FASEB J 2005 ; 19 : 583–585. [PubMed]
  14. Porras G, Berthet A, Dehay B, et al. PSD-95 expression controls l-DOPA dyskinesia through dopamine D1 receptor trafficking. J Clin Invest 2012 ; 122 : 3977–3989. [CrossRef] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.